ISOLATED ALTERATIONS OF BIOCHEMICAL MARKERS OF LIVER DAMAGE in a
seemingly healthy patient can present a challenge for the clinician. In this review we provide …

Patients with hepatocellular carcinoma should be managed with a multidisciplinary
approach framed in a network where all the diagnostic techniques and therapeutic …

Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of
liver function (ie, presence or absence of portal hypertension, model for end-stage liver …

Background The aspartate aminotransferase–alanine aminotransferase ratio (AST/ALT
ratio) has been used to noninvasively assess the severity of disease in patients with chronic …

METHODS A total of 218 cirrhotic patients underwent screening endoscopy for EV. Platelet
count/spleen diameter ratio ((N/mm 3)/mm) was assessed in all patients and its diagnostic …

Background Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated
the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet …

BACKGROUND & AIMS: The current guidelines recommend the surveillance of cirrhotic
patients for early diagnosis of hepatocellular carcinoma (HCC), based on liver …

The ratio of serum aspartate aminotransferase toalanine aminotransferase (AST/ALT ratio)
has beenproposed as a noninvasive method of assessing liverfibrosis and cirrhosis. Our …

The prognosis of untreated patients with hepatocellular carcinoma (HCC) is heterogeneous,
and survival data were mainly obtained from control arms of randomized studies. Clinical …

The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …